Post COVID fatigue: AETL’ supplements pass trials
The Hindu
Study was conducted on 200 patients across three centres
Advanced Enzyme Technologies Ltd (AETL) has said its systemic enzyme and probiotic supplements—ImmunoSEB and ProbioSEB CSC3 have passed the randomised controlled clinical trials in terms of efficacy to resolve post COVID-19 fatigue symptoms. “With an aim to evaluate the efficacy and safety of the health supplements, ImmunoSEB [systemic enzyme complex] and ProbioSEB CSC3 [probiotic complex] in patients suffering from COVID-19 induced fatigue, a randomised, multi-centric, double blind and placebo-controlled trial was conducted in 200 patients suffering from post COVID-19 fatigue symptoms,” said Dr. Abhijit K. Rathi, Principal Scientist, AETL. “The randomized clinical trial was conducted on 200 patients who did not have an active SARS-CoV-2 infection, as determined by a negative COVID-19 test, with a complaint of post COVID-19 fatigue,” he stated.More Related News

The High Court of Karnataka on Tuesday ordered the issue of a notice to the State government on a PIL petition, which had complained about disturbances caused to people residing in the localities around the National Public School situated in Rajajinagar 5th block due to use of loudspeakers with high volume in the school and parking of school buses in residential areas.












